ArticleCurrent research in food science2025
The three-dimensional structure prediction of human bitter taste receptor using the method of AlphaFold3.
Article in Current research in food science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bitter taste receptors (T2Rs), a subfamily of G protein-coupled receptors, are expressed not only in oral tissues but also in extraoral sites, playing key roles in physiological processes such as the gut-brain axis. However, structural information on T2Rs is limited, with only two human T2Rs, T2R14 and T2R46, experimentally determined to date. This study explores the potential of AlphaFold3 (AF3), an advanced AI-based protein structure prediction tool, to predict the structures of 25 human T2Rs and compares them with those of the earlier AlphaFold2 (AF2). The accuracy of AF3 was evaluated by comparing the predicted structures of T2R14 and T2R46 with known experimental structures. Our results show that AF3 provides more accurate structural predictions than AF2 for these receptors, though the predicted local distance difference test scores for AF3 were unexpectedly lower across all T2R subtypes. Subsequent analysis indicated that significant structural variations were observed in the receptor's extracellular region, in contrast to a higher degree of structural consistency in the intracellular region. Clustering based on sequence identity and root mean square deviation highlighted distinct groupings among the receptors. The structural properties of these T2Rs may be related to their ability to recognize thousands of diverse bitter substances through interaction with the taste receptor-specific G protein, α-gustducin. The present study provides evidence that AF3 can advance our understanding of T2R structure and research into the biological activity of T2R-ligand interactions in health-related processes, including risk reduction of obesity and diabetes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.